Systemic immunity-inflammation index is associated with body fat distribution among U.S. adults: evidence from national health and nutrition examination survey 2011-2018.
Xue Liu, Yuhao Zhang, Yuchen Li...
https://pubmed.ncbi.nlm.nih.gov/39294646/Actively Recruiting
Led by University of Rijeka · Updated on 2026-05-07
200
Participants Needed
1
Research Sites
35 weeks
Total Duration
This research aims to evaluate how two blood-based inflammation markers, the systemic immune-inflammatory index SII and the systemic inflammation response index SIRI, relate to overweight and obesity. The study focuses on their diagnostic and prognostic value regarding obesity severity, metabolic complications, lifestyle habits, dietary patterns, and inflammation in adults with overweight or obesity. It seeks to understand if these markers can help predict metabolic risks and outcomes from obesity treatments. Participants will undergo detailed assessments including body measurements, blood tests for various biomarkers, and dietary evaluations. They will receive motivational counseling and follow-up visits at baseline, 12 weeks, and 24 weeks, with ongoing monitoring over a year. Treatments such as lifestyle changes, medications, or bariatric surgery will be followed but are chosen as part of routine care, not assigned by the study. During the study, participants will complete questionnaires on lifestyle and diet, and have multiple laboratory tests to track inflammation and metabolic health. Researchers will monitor changes in SII and SIRI and their associations with treatment responses and metabolic outcomes. The main goal is to understand the predictive value of these inflammation markers over an average of one year, with comprehensive data collection at several time points.
CONDITIONS
Prognostic Value of SII and SIRI in Obesity-Related Metabolic Complications
G
Gordana Kenđel Jovanović, Asst.Prof.
J
Jelena Vresk Špiranec, MD, spec. endocrinology
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Rijeka
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants complete baseline measurements including anthropometrics, blood sampling, dietary evaluation, and receive motivational and educational counselling on diet, activity, and pharmacotherapy options.
1 baseline visit (in-person)
Duration - Up to 24 weeks
Participants return for follow-up visits to repeat anthropometric and laboratory assessments, evaluate dietary and lifestyle adherence, and receive motivational counselling.
2 visits (in-person or telephone) at Week 12 and Week 24
Duration - Approximately 1 year
Participants are monitored for metabolic outcomes and obesity treatment response over one year, including prognostic assessment of inflammatory indices.
Structured follow-up assessments at 12 and 24 weeks and ongoing monitoring up to 1 year
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Xue Liu, Yuhao Zhang, Yuchen Li...
https://pubmed.ncbi.nlm.nih.gov/39294646/Luigi Barrea, Ludovica Verde, Giuseppe Annunziata...
https://pubmed.ncbi.nlm.nih.gov/40920291/Yayun Liao, Kejian Zhou, Baoquan Lin...
https://pubmed.ncbi.nlm.nih.gov/39885869/Yaoyao Zhou, Yaqi Wang, Taotao Wu...
https://pubmed.ncbi.nlm.nih.gov/39127686/Linjie Qiu, Yan Ren, Jixin Li...
https://pubmed.ncbi.nlm.nih.gov/39069464/Mohit Mirchandani, Herby Jeanty, Satabdi Sahu...
https://pubmed.ncbi.nlm.nih.gov/41377417/Yu-Zhen Zhang, Run-Wei Ma, Suwas Bhandari...
https://pubmed.ncbi.nlm.nih.gov/39987171/Hafize Uzun, Aysen Kutan Fenercioglu, Abdulhalim Senyigit...
https://pubmed.ncbi.nlm.nih.gov/41374089/Sanaz Asemani, Neda Jourabchi-Ghadim, Sara Arefhosseini...
https://pubmed.ncbi.nlm.nih.gov/40247599/Martina Galasso, Ludovica Verde, Luigi Barrea...
https://pubmed.ncbi.nlm.nih.gov/40381089/University of Rijeka
Lead Sponsor